CAMBRIDGE NEWS: CONGENICA DEAL WITH NHSA TO HELP CUT DIAGNOSIS TIMES FOR RARE GENETIC DISEASES
CAMBRIDGE NEWS: CONGENICA DEAL WITH NHSA TO HELP CUT DIAGNOSIS TIMES FOR RARE GENETIC DISEASES
20th May 2016
A Cambridge company’s technology which can cut the diagnosis times for rare genetic diseases is being made available on the NHS.
Related News Articles
NHSA CEO responds to Prime Minister's innovation speech
Hannah Davies, CEO of the Northern Health Science Alliance, responds to the Prime Minister's speech at the Innovation Nation Summit.
Read the article‘Hidden’ inequalities facing minority ethnic women in the North exposed in groundbreaking report
The latest Woman of the North report exposes 'hidden' inequalities facing minority ethnic women
Read the articleNew report sets out roadmap to strengthen collaboration across the North’s health research ecosystem
A new report from the Northern Health Science Alliance (NHSA), commissioned and funded by the Academy of Medical Sciences, has identified practical steps to make it easier for researchers, clinicians, industry, policymakers and other partners to collaborate across the North of England.
Read the article